 |
|
|
| |
Patient characteristics and utilization of protease inhibitors in hepatitis C virus (HCV) patients in a large payer database
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Neeta Tandon1, Candace Gunnarsson2, Avinash Prabhakar3
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2S2 Statistical Solutions, Inc., Cincinnati, OH, USA; 3Janssen Services, LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
